Recital 7, Commission Regulation (EC) No 984/2009 of 21 October 2009 refusing to authorise certain…

In forcesince 21 Oct 2009

Following an application from Valio Ltd submitted on 8 July 2008, pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of LGG® MAX on gastro-intestinal discomfort (Question No EFSA-Q-2008-444) [The EFSA Journal (2008) 853, pp. 1-2.]. The claim proposed by the applicant was worded as follows: ‘LGG® MAX helps to reduce gastro-intestinal discomfort’.